Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Breast Cancer and Ovarian Cancer”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Looking for participantsNCT07503808
What this trial is testing

IDE034 in Adult Participants With Locally Advanced/Metastatic Solid Tumors Types

Who this might be right for
Esophageal Squamous Cell CarcinomaHigh Grade Serous Ovarian CancerHead and Neck Squamous Cell Carcinoma+5 more
IDEAYA Biosciences 150
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07610733
What this trial is testing

Impact of Formulation Change on Ovarian Suppression in Young Breast Cancer Patients.

Who this might be right for
Breast Cancer
Fudan University 100
Early research (Phase 1)Study completedNCT04430842
What this trial is testing

Dose Escalation Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of QBS10072S

Who this might be right for
AstrocytomaBrain CancerBrain Metastases+20 more
Quadriga Biosciences, Inc. 15
Testing effectiveness (Phase 2)Study completedNCT01367639
What this trial is testing

Trial of Inquiry Based Stress Reduction (IBSR) Program for BRCA1/2 Mutation Carriers

Who this might be right for
Hereditary Breast and Ovarian Cancer Syndrome
Sheba Medical Center 67
Testing effectiveness (Phase 2)Study completedNCT02762981
What this trial is testing

Study to Evaluate Relacorilant (CORT125134) in Combination With Nab-paclitaxel in Participants With Solid Tumors

Who this might be right for
Solid Tumors
Corcept Therapeutics 85
Testing effectiveness (Phase 2)Study completedNCT01618136
What this trial is testing

An Open-Label, Multicenter, Phase 1/2 Study of Poly(ADP-Ribose) Polymerase (PARP) Inhibitor E7449 as Single Agent in Subjects With Advanced Solid Tumors or With B-cell Malignancies and in Combination With Temozolomide (TMZ) or With Carboplatin and Paclitaxel in Subjects With Advanced Solid Tumors

Who this might be right for
Malignant Solid TumourOvarian CancerTriple Negative Breast Cancer+2 more
Eisai Limited 41
Not applicableStudy completedNCT04544501
What this trial is testing

Enhance the Use of Genetic Counseling and Testing in Latinas

Who this might be right for
Hereditary Breast and Ovarian Cancer Syndrome
Georgetown University 61
Not applicableUnknownNCT05763472
What this trial is testing

Breast Cancer After Ovarian Cancer During and/or After Therapy: Genomic Evaluation

Who this might be right for
BRCA-Associated Breast Carcinoma
Fondazione Policlinico Universitario Agostino Gemelli IRCCS 10
Testing effectiveness (Phase 2)Study completedNCT00204477
What this trial is testing

Soy Protein and Breast Cancer Risk Reduction

Who this might be right for
Breast Cancer
The University of Texas Medical Branch, Galveston 321
Not applicableStudy completedNCT04726319
What this trial is testing

Family History App in Personalized Medicine

Who this might be right for
Cancer, BreastCancer, OvarianCancer, Colorectal+4 more
University of Toronto 627
Not applicableStudy completedNCT00040222
What this trial is testing

Clinical, Genetic, Behavioral, Laboratory and Epidemiologic Characterization of Individuals and Families at High Risk of Breast/Ovarian Cancer

Who this might be right for
Familial Ovarian CancerFamilial Breast CancerBRCA1-associate Malignancies+1 more
National Cancer Institute (NCI) 377
Not applicableNot Yet RecruitingNCT07814872
What this trial is testing

A Preregistered Multi-Cohort Evaluation of the FATHOM AI System for Molecular Testing Prioritization to Support Clinical Trial Enrollment

Who this might be right for
Neoplasms (Cancer / Tumors)Colorectal NeoplasmsLung Neoplasms+8 more
Harvard Medical School (HMS and HSDM) 30,000
Early research (Phase 1)UnknownNCT05311618
What this trial is testing

Study of NGM438 as Monotherapy and in Combination With Pembrolizumab in Advanced or Metastatic Solid Tumors

Who this might be right for
Pancreatic CancerBreast CancerGastric Cancer+13 more
NGM Biopharmaceuticals, Inc 71
Testing effectiveness (Phase 2)Study completedNCT00316407
What this trial is testing

Lapatinib/Carboplatin/Paclitaxel in Previously Treated Ovarian or Breast Cancer Patients

Who this might be right for
Ovarian Epithelial Cancer Stage IIIStage IV Ovarian CancerStage IV Breast Cancer
Swedish Medical Center 30
Very early researchNot Yet RecruitingNCT07781852
What this trial is testing

Evaluation of the Distribution of 64Cu/68Ga Labeled CM500 in Healthy Volunteers and Patients With Cancer

Who this might be right for
Bladder CancerGliomaGlioblastoma (GBM)+13 more
Lumina Pharmaceuticals Inc 40
Not applicableWithdrawnNCT00898612
What this trial is testing

Early Detection of Graft-Versus-Host Disease in Patients Undergoing a Donor Bone Marrow Transplant

Who this might be right for
Lymphoma
Mayo Clinic
Not applicableLooking for participantsNCT05142033
What this trial is testing

Avera Cancer Sequencing and Analytics Protocol (ASAP)

Who this might be right for
CancerCancer DiagnosisEarly Detection of Cancer+9 more
Avera McKennan Hospital & University Health Center 25,000
Early research (Phase 1)Study completedNCT01484015
What this trial is testing

Prolonged or Standard Infusion of Cefepime Hydrochloride in Treating Patients With Febrile Neutropenia

Who this might be right for
Adult Acute Lymphoblastic LeukemiaAdult Acute Myeloid LeukemiaAdult Burkitt Lymphoma+36 more
Wake Forest University Health Sciences 70
Early research (Phase 1)Looking for participantsNCT04038619
What this trial is testing

Fecal Microbiota Transplantation in Treating Immune-Checkpoint Inhibitor Induced-Diarrhea or Colitis in Genitourinary Cancer Patients

Who this might be right for
ColitisDiarrheaMalignant Genitourinary System Neoplasm+6 more
M.D. Anderson Cancer Center 40
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06531486
What this trial is testing

XS-02 Capsules in Patients With Advanced Solid Tumors

Who this might be right for
Solid TumorOvarian CancerBreast Cancer+1 more
NovaOnco Therapeutics Co., Ltd. 96
Next Page